Integra LifeSciences Forecasts Fiscal Year 2024 Adjusted EPS Of $3.15-$3.25 Versus Consensus Of $3.44
Portfolio Pulse from Benzinga Newsdesk
Integra LifeSciences projects its adjusted EPS for fiscal year 2024 to be in the range of $3.15-$3.25, which is below the consensus estimate of $3.44.
February 28, 2024 | 11:07 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Integra LifeSciences forecasts its adjusted EPS for fiscal year 2024 to be $3.15-$3.25, below the consensus of $3.44.
The projected EPS by Integra LifeSciences for fiscal year 2024 is significantly below the consensus estimates, which could lead to negative investor sentiment and potentially a decrease in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100